Top

Published in:

01-10-2012 | Original Article

Prognostic significance of FLT3 internal tandem duplication in Egyptian acute myeloid leukemia and normal cytogenetics

Authors: Rabab Aly, Dina Shahin, Emad Azmy

Published in: Comparative Clinical Pathology | Issue 5/2012

Abstract

Internal tandem duplication of the FLT3 gene (FLT3/ITD) has been linked to a poor outcome in acute myeloid leukemia (AML). However, the prognostic value of FLT3/ITD in various cytogenetic risk groups is still a matter of debate. The aim of this study was to evaluate the prognostic significance of FLT3/ITD in patients with de novo AML and normal cytogenetics (NC-AML). Diagnostic samples of 39 patients were investigated by PCR of exons 14 and 15 of the FLT3 gene in patients with AML. Subgroups included 26 patients with normal cytogenetics, 8 patients with t(15;17), 4 patients with t(8;21), and 1 patient with inv (16). FLT3/ITD was found in 6/39 (15.4%) AML cases. By cytogenetic subgroups, there were 4/6 normal cytogenetics, 1/6 t(15;17) and 1/6 t(8;21) positive patients. Patients were M1, 3/13; M2, 2/12; M3, 1/9; M4, 0/4; and M5, 0/1. The patients were followed up for a mean of 34.5 ± 2.3 months. The complete remission rates for the FLT3/ITD+ and FLT/ITD− groups were 50% vs 63.6% in normal cytogenetics, while the relapse rates were 50% vs 28.6% in normal cytogenetics. Interestingly, disease-free survival (DFS) at 3 years was significantly different in patients with normal cytogenetics: DFS was 5% in patients with FLT3/ITD+ vs 30% of patients with FLT3/ITD− (P = 0.001). Although based on a study with a limited number of AML patients, our data suggest a high prognostic value of FLT3/ITD in patients with normal/favorable cytogenetics. Further study on a larger scale is recommended.

Arrigoni P, Beretta C, Silvestri D et al (2003) FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia. Br J Haematol 120:89–92PubMedCrossRef

Bacher U, Haferlach T, Schoch C, Kern W, Schnittger S (2006) Implications of NRAS mutations in AML: a study of 2502. Blood 107:3847–3853PubMedCrossRef

Bao L, Wang X, Ryder J et al (2006) Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and FLT3 mutation. Eur J Haematol 77:35–45PubMedCrossRef

Beitinjaneh A, Jang S, Roukoz H, Majhail NS (2010) Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukaemia: a systematic review. Leukemia Res 34:831–836CrossRef

Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T (2005) Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Clin Cancer Res 11(4):1416–1424PubMedCrossRef

Bloomfield CD (1992) Prognostic factors for selecting curative therapy for adult acute myeloid leukemia. Leukemia 6:65–67PubMed

Bloomfield CD, Shuma C, Regal L et al (1997) Long term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 80:2191–2198PubMedCrossRef

Ciolli S, Vannucchi AM, Leoni F, Nozzoli C, Longo G, Salati A, Pancrazzi A, Bianchi L, Gigli F, Bosi A (2004) Internal tandem duplications of Flt3 gene (Flt3/ITD) predicts a poor postremission outcome in adult patients with acute non promyelocytic leukemia. Leuk Lymphoma 45(1):73–78PubMedCrossRef

Fenski R, Flesch K, Serve S et al (2000) Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells. Br J Haematol 108:322–330PubMedCrossRef

Fröhling S, Schlenk RF, Breitruck J, Benner A, Kreitmeier S, Tobis K, Döhner H, Döhner K (2002) Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm. Blood 100(13):4372–4380PubMedCrossRef

Gilliland DG, Griffin JD (2002a) The roles of FLT3 in hematopoiesis and leukemia. Blood 100:1532–1542PubMedCrossRef

Gilliland DG, Griffin JD (2002b) Role of FLT3 in leukemia. Curr Opin Hematol 9:274–281PubMedCrossRef

Gregory TK, Wald D, Chen Y, Vermaat JM, Xiong Y, Tse W (2009) Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics. J Hematol Oncol 2:23PubMedCrossRef

Grimwad D, Walker H, Oliver F et al (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukemia Working Parties. Blood 92:2322–2333

Illmer T, Thiede C, Fredersdorf A et al (2005) Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts. Clin Cancer Res 11:3217–3224PubMedCrossRef

Kainz B, Heintel D, Marculescu R, Schwarzinger I, Sperr W, Le T, Weltermann A, Fonatsch C, Haas OA, Mannhalter C, Lechner K, Jaeger U (2002) Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15; 17), t(8;21) or inv(16). Hematol J 3:283–289PubMedCrossRef

Kim YK, Lee JJ, Lee YR, Lee IK, Kim HN, Kim NY, Park KS, Yang DH, Park MR, Kim HJ (2004) The presence of FLT3/ITD mutations is an independent prognostic factor in acute myeloid leukemia patients with normal karyotype. Blood 104:3008a

Kiyoi H, Naoe T (2006a) Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation. Int J Hematol 83(4):301–308PubMedCrossRef

Kiyoi H, Naoe T (2006b) FLT3 mutations in acute myeloid leukemia. Methods Mol Med 125:189–197PubMed

Kiyoi H, Towatari M, Yokota S et al (1998) Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia 12:1333–1337PubMedCrossRef

Kondo M, Horibe K, Takahashi Y et al (1999) Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia. Med Pediatr Oncol 33:525–529PubMedCrossRef

Kottaridis PD, Gale RE, Frew ME et al (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 98:1752–1759PubMedCrossRef

Kottaridis P, Gale RE, Linch DC (2003) FLT3 mutations and leukemia. Br J Haematol 122:523–538PubMedCrossRef

Kumiko O, Sakurako Y, Sumio K et al (2005) Activating mutations of FLT3 gene in childhood acute myeloid leukemia and their applications for detection of minimal residual disease. Japan J Pediatr Hematol 19:19–24

Liang DC, Shih LY, Hung IJ et al (2002) Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia. Cancer 94:3292–3298PubMedCrossRef

Meierhoff G, Dehmel U, Gruss H et al (1995) Expression of Flt3 receptor and Flt3-ligand in human leukemia-lymphoma cell lines. Leukemia 9:1368–1372PubMed

Meshinchi S, Woods WG, Stirewalt DL et al (2001) Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 97:89–94PubMedCrossRef

Meshinchi S, Alonzo TA, Stirewalt DL et al (2006) Clinical implications of FLT3 mutations in pediatric AML. Blood 108:3654–3661PubMedCrossRef

Mitelman F (ed) (1991) An international system for human cytogenetic nomenclature. Karger, Basel

Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K et al (1996) Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia. Leukemia 10:1911–1918PubMed

Ozeki K, Kiyoi H, Hirose Yet al (2004) Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood 103(5):1901–1908

Pazhakh V, Zaker F, Alimoghaddam K, Atashrazm F (2011) Detection of nucleophosmin and FMSlike tyrosine kinase 3 gene mutations in acute myeloid leukemia. Ann Saudi Med 31:45–50PubMedCrossRef

Rombouts WJ, Blokland I, Lowenberg B, Ploemacher RE (2000) Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3. Leukemia 14:675–683PubMedCrossRef

Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Loffler H, Sauerland CM, Serve H, Buchner T, Haferlach T, Hiddemann W (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 100:59–66PubMedCrossRef

Shih LY, Huang CF, Wu JH, Lin TL, Dunn P, Wang PN, Kuo MC, Lai CL, Hsu HC (2002) Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse. Blood 100:2387–2392PubMedCrossRef

Stirewalt DL, Radich JP (2003) The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer 3:650–665PubMedCrossRef

Stirewalt DL, Meshinchi S, Kussick SJ et al (2004) Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia. Br J Haematol 124:481–484PubMedCrossRef

Thiede C, Steudel C, Mohr B et al (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99:4326–4335PubMedCrossRef

Xu F, Taki T, Yang H et al (1999) Tandem duplication of the Flt3 gene is found in acute lymphoblastic leukemia as well as acute myeloid leukemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukemia in children. Br J Haematol 105:155–162PubMedCrossRef

Xu F, Taki T, Eguchi M et al (2000) Tandem duplication of the FLT3 gene is infrequent in infant acute leukemia. Japan Infant Leukemia Study Group. Leukemia 14:945–947PubMedCrossRef

Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S et al (2001) Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97:2434–2439PubMedCrossRef

Yanada M, Matsuo K, Suzuki T, Kiyoi H, Naoe T (2005) Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase mutations for acute myeloid leukemia: a meta-analysis. Leukemia 19:1345–1349PubMedCrossRef

Yokota S, Kiyoi H, Nakao M et al (1997) Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies: a study on a large series of patients and cell lines. Leukemia 11:1605–1609PubMedCrossRef

Zheng R, Small D (2005) Mutant FLT3 signaling contributes to a block in myeloid differentiation. Leuk Lymphoma 46(12):1679–1687PubMedCrossRef

Zwaan CM, Meshinchi S, Radich JP et al (2003) FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. Blood 102:2387–2394PubMedCrossRef

Title: Prognostic significance of FLT3 internal tandem duplication in Egyptian acute myeloid leukemia and normal cytogenetics
Authors: Rabab Aly
Dina Shahin
Emad Azmy
Publication date: 01-10-2012
Publisher: Springer-Verlag
Published in: Comparative Clinical Pathology / Issue 5/2012
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI: https://doi.org/10.1007/s00580-011-1223-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prognostic significance of FLT3 internal tandem duplication in Egyptian acute myeloid leukemia and normal cytogenetics

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2012

Dermoid cyst in camel: a case report and brief literature review

Seasonal changes of blood serum biochemistry in relation to sexual maturation of female common carp (Cyprinus carpio)

The modulatory role of cortisol on prolactin secretion in anestrus Iranian fat-tailed ewes

A comparative study on the biochemical parameters of seminal and blood plasma and their correlation in the wild common carp (Cyprinus carpio)

Investigation on the occurrence and pathology of paratuberculosis (Johne’s disease) in apparently healthy cattle in Jordan

Use of the platelet function analyser PFA-100™ in juvenile pigs